Applications are now open for our 2024/2025 PhD studentships. Below you will find a link to further information about our application process, our application portal and mailing list, should you wish ...
Help women with ovarian and breast cancer live longer and better lives by supporting the Institute of Cancer Research. Donate ...
A three-drug combination for aggressive advanced breast cancer doubles the length of time before the cancer progresses, ...
Cancer Research UK (CRUK) has awarded The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust a ...
A new imaging technique could mean patients with aggressive brain tumours benefit from cutting edge immunotherapy treatments, ...
This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. Diana Cano, Ichha Khanal, ...
Scientists have pinpointed thousands of genetic changes in a gene that may increase a person’s risk of developing breast and ovarian cancer, paving the way for better risk assessment and more ...
Our excellence in working with industry and academia, and in engaging with the wider public has been highlighted in an important analysis. The latest Knowledge Exchange Framework – ‘KEF’ for short – ...
Image: Leiomyosarcoma. Credit: Wikimedia Commons. A new study has answered the long-standing question of why improvements in survival outcomes for young people with cancerous soft tissue tumours have ...
Image: AI-generated DNA. Credit: Ivana TomáÅ¡ková from Pixabay. Researchers have examined thousands of genetically defined traits to identify possible causal relationships for eight common cancers. The ...
A pioneering apprenticeship programme for aspiring laboratory research technicians has won the Education and Training Award at the UK Pharma Industry Awards. The programme at The Institute of Cancer ...
A charity fundraising event that was set up as a tribute to Dave Myers, the much-loved TV chef, raised an incredible £63,169.32 for The Institute of Cancer Research, London. Dave, who was one half of ...